Squarepoint
HURA

Squarepoint’s TuHURA Biosciences HURA Stock Holding History

Squarepoint’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.8K Buy
+34,528
New +$80.4K ﹤0.01% 4230
2025
Q2 		– Sell
-12,506
Closed -$40.4K – 5193
2025
Q1 		$40.4K Sell
12,506
-42,029
-77% -$155K ﹤0.01% 4375
2024
Q4 		$223K Buy
+54,535
New +$290K ﹤0.01% 4386
2021
Q1 		– Sell
-7
Closed -$15K – 3703
2020
Q4 		$15K Buy
+7
New +$17.6K ﹤0.01% 2843

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Squarepoint's HURA Position: Q2 2026 in Review

Squarepoint opened a new position in TuHURA Biosciences (HURA) in Q2 2026: 34,528 shares worth $80.8K. The stake represents ﹤0.01% of the portfolio and ranks #4230 among its holdings. This is a return to the name: Squarepoint previously reported a position in HURA as recently as Q1 2025.

Squarepoint first reported a position in HURA in Q4 2020 and has held it in 4 quarters since. The position peaked at $223K in Q4 2024. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Squarepoint held 34,528 shares of TuHURA Biosciences worth $80.8K as of Q2 2026.
  • TuHURA Biosciences was a new Squarepoint position in Q2 2026.
  • TuHURA Biosciences made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4230 holding.
  • Squarepoint first reported a position in TuHURA Biosciences in Q4 2020 and has held it in 4 quarters since.
  • Squarepoint's TuHURA Biosciences position peaked at $223K in Q4 2024.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.